Home > Healthcare > Medical Devices > Therapeutic Devices > Hearing Amplifiers Market
Hearing amplifiers market size from the behind-the-ear product segment is anticipated to record 4.3% CAGR between 2023-2032. The surging demand for behind-the-ear (BTE) hearing amplifiers can be attributed to numerous innovative features offered by these devices, such as greater battery life, and multi settings. These technologies are composed of next-generation modalities and allow variations due to their bigger size. Moreover, the increasing availability of over-the-counter (OTC) BTE hearing devices at affordable pricing will positively influence the industry expansion.
Hearing amplifiers market from digital technology is projected to register 5.2% CAGR between 2023-2032. Digital technologies are rapidly penetrating the healthcare sector with the growing need for digitization of an array of services. Digital systems offer a wide variety of benefits, including high efficiency, fine detail, configurability, and noise immunity. Moreover, the ongoing advancement in different software is helping improve audio-processing design, enabling easier faster modifications without any significant impact on the design schedule.
In terms of revenue, the hearing amplifiers market share from e-commerce distribution channels is poised to reach over USD 48 million by 2032. The rapid influx of online platforms and digital portables providing medical devices and consumer electronics are making way for a massive consumer base owing to the greater convenience and ease of purchasing. Additionally, the outbreak of the COVID-19 pandemic significantly accelerated e-commerce spending, particularly for medical supplies and medications. Furthermore, the advent of E-pharmacy across developing countries, such as India will consolidate the sale of hearing amplifiers across digital platforms.
North America accounted for more than 37% of the hearing amplifiers market share in 2022 owing to the increasing prevalence of deafness and hearing loss in the region. According to the Centers for Disease Control & Prevention (CDC), and the Hearing Loss Association of America (HLAA) more than 45 million of the U.S. population suffer from some degree of hearing impairment. Additionally, the promising product penetration and acceptance across countries such as the U.S. and Canada are anticipated to offer lucrative business prospects for the leading regional industry players. For instance, in February 2023, Medline announced a collaboration with MDHearing, a Chicago-based D2C hearing aid company, to enhance access to affordable hearing aids without the need for a prescription.